SER150

SER150 (formerly EV 077) is an inhibitor of thromboxane synthase and an antagonist of the thromboxane prostanoid receptor. It was developed for diabetic nephropathy.
Wikipedia contributors, "SER150", Wikipedia, revision 1361912955, retrieved 20 November 2026, source, CC BY-SA 4.0.